Rational drug design approach for overcoming drug resistance: application to pyrimethamine resistance in malaria

Journal of Medicinal Chemistry
J H McKieWorachart Sirawaraporn

Abstract

Pyrimethamine acts by selectively inhibiting malarial dihydrofolate reductase-thymidylate synthase (DHFR-TS). Resistance in the most important human parasite, Plasmodium falciparum, initially results from an S108N mutation in the DHFR domain, with additional mutation (most commonly C59R or N51I or both) imparting much greater resistance. From a homology model of the 3-D structure of DHFR-TS, rational drug design techniques have been used to design and subsequently synthesize inhibitors able to overcome malarial pyrimethamine resistance. Compared to pyrimethamine (Ki 1.5 nM) with purified recombinant DHFR fromP. falciparum, the Ki value of the m-methoxy analogue of pyrimethamine was 1.07 nM, but against the DHFR bearing the double mutation (C59R + S108N), the Ki values for pyrimethamine and the m-methoxy analogue were 71.7 and 14.0 nM, respectively. The m-chloro analogue of pyrimethamine was a stronger inhibitor of both wild-type DHFR (with Ki 0.30 nM) and the doubly mutant (C59R +S108N) purified enzyme (with Ki 2.40 nM). Growth of parasite cultures of P. falciparum in vitro was also strongly inhibited by these compounds with 50% inhibition of growth occurring at 3.7 microM for the m-methoxy and 0.6 microM for the m-chloro compo...Continue Reading

References

Jun 1, 1992·Molecular and Biochemical Parasitology·S ThaithongG Beale
Dec 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·D S PetersonT E Wellems
Dec 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·A F CowmanS J Foote
Feb 18, 1997·Proceedings of the National Academy of Sciences of the United States of America·W SirawarapornD V Santi
Jan 1, 1994·Parasitology Today·K T Douglas

❮ Previous
Next ❯

Citations

Oct 19, 2005·Journal of Computer-aided Molecular Design·Claudia MachicadoJavier Sancho
Feb 19, 2002·Molecular and Biochemical Parasitology·Sudsanguan ChusacultanachaiYongyuth Yuthavong
Sep 28, 2000·Parasitology Today·I MacreadieL Tilley
Mar 7, 2002·Microbes and Infection·John E Hyde
Mar 7, 2002·Microbes and Infection·Yongyuth Yuthavong
Feb 19, 2005·Drug Discovery Today·Amy C Anderson
Dec 3, 2010·PLoS Pathogens·Isabel M VincentMichael P Barrett
Jul 18, 2012·Future Medicinal Chemistry·Moni Sharma, Prem M S Chauhan
Jul 31, 2007·Future Microbiology·Yongyuth YuthavongPenchit Chitnumsub
Aug 16, 2011·Biochimica Et Biophysica Acta·N M GoodeyK C Bagley
Nov 17, 2015·SAR and QSAR in Environmental Research·R Medina MarreroF Pérez-Giménez
Apr 23, 2005·Acta Tropica·John E Hyde
May 24, 2011·Enzyme Research·Patrícia Soares de Maria de MedeirosLuiz Hildebrando Pereira da Silva
Oct 22, 2014·Journal of Biomolecular Structure & Dynamics·Sheenu AbbatPrasad V Bharatam
Apr 22, 2003·Nature Structural Biology·Jirundon YuvaniyamaYongyuth Yuthavong
Mar 1, 2005·Pharmacological Reviews·Aric Gregson, Christopher V Plowe
Nov 3, 2007·Current Opinion in Infectious Diseases·Timothy J Egan, Catherine H Kaschula
Dec 10, 2009·Journal of Enzyme Inhibition and Medicinal Chemistry·Legesse AdaneVikas Sharma
Sep 24, 2020·Molecular Informatics·Conrad V SimobenFidele Ntie-Kang
Oct 24, 1998·Infection and Immunity·R E VerdunD O Sanchez
Nov 10, 2006·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·W Sirawaraporn
Aug 13, 2011·Journal of Chemical Information and Modeling·Tiejun ChengStephen H Bryant
Jan 23, 2004·Journal of Medicinal Chemistry·Sumalee KamchonwongpaisanYongyuth Yuthavong

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.